JPS628432B2 - - Google Patents
Info
- Publication number
- JPS628432B2 JPS628432B2 JP1497884A JP1497884A JPS628432B2 JP S628432 B2 JPS628432 B2 JP S628432B2 JP 1497884 A JP1497884 A JP 1497884A JP 1497884 A JP1497884 A JP 1497884A JP S628432 B2 JPS628432 B2 JP S628432B2
- Authority
- JP
- Japan
- Prior art keywords
- propyl
- benzopyran
- hydroxy
- dihydro
- acetyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 161
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 14
- -1 hydroxy-2-propylphenoxy Chemical group 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 235000019260 propionic acid Nutrition 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- WMSJUOPBEKQYTQ-UHFFFAOYSA-N methyl 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-2h-chromen-2-yl]propanoate Chemical compound C1=CC(C(C)=O)=C(O)C(CCC)=C1OCCCOC1=CC=C(C=CC(CCC(=O)OC)O2)C2=C1CCC WMSJUOPBEKQYTQ-UHFFFAOYSA-N 0.000 claims description 2
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 90
- 238000000921 elemental analysis Methods 0.000 description 88
- 238000002329 infrared spectrum Methods 0.000 description 51
- 239000000243 solution Substances 0.000 description 51
- 239000000047 product Substances 0.000 description 45
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- 238000000034 method Methods 0.000 description 42
- 238000002844 melting Methods 0.000 description 39
- 230000008018 melting Effects 0.000 description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 26
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 24
- 150000002148 esters Chemical class 0.000 description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 21
- 239000000741 silica gel Substances 0.000 description 21
- 229910002027 silica gel Inorganic materials 0.000 description 21
- 239000007858 starting material Substances 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 125000003118 aryl group Chemical group 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000012267 brine Substances 0.000 description 14
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 14
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 12
- 239000003480 eluent Substances 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 11
- 235000019341 magnesium sulphate Nutrition 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 9
- QGGRBWUQXAFYEC-UHFFFAOYSA-N 1-(2,4-dihydroxy-3-propylphenyl)ethanone Chemical compound CCCC1=C(O)C=CC(C(C)=O)=C1O QGGRBWUQXAFYEC-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 238000004587 chromatography analysis Methods 0.000 description 8
- 238000007429 general method Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 230000008034 disappearance Effects 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 238000002211 ultraviolet spectrum Methods 0.000 description 6
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 4
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 4
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical compound OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 206010006482 Bronchospasm Diseases 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 230000007885 bronchoconstriction Effects 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000004968 inflammatory condition Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- ZDEVPOBNLIVGFA-UHFFFAOYSA-M sodium;7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propylchromene-2-carboxylate Chemical compound [Na+].CCCC1=C(O)C(C(C)=O)=CC=C1OCC(O)COC1=CC=C2C(=O)C=C(C([O-])=O)OC2=C1CCC ZDEVPOBNLIVGFA-UHFFFAOYSA-M 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- GMEONFUTDYJSNV-UHFFFAOYSA-N Ethyl levulinate Chemical group CCOC(=O)CCC(C)=O GMEONFUTDYJSNV-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- PPTSBERGOGHCHC-UHFFFAOYSA-N boron lithium Chemical compound [Li].[B] PPTSBERGOGHCHC-UHFFFAOYSA-N 0.000 description 2
- 239000004044 bronchoconstricting agent Substances 0.000 description 2
- 230000003435 bronchoconstrictive effect Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 2
- ATWLRNODAYAMQS-UHFFFAOYSA-N 1,1-dibromopropane Chemical compound CCC(Br)Br ATWLRNODAYAMQS-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- PGGZAZHZNVKDLG-UHFFFAOYSA-N 1,4-dioxane;hexane Chemical compound CCCCCC.C1COCCO1 PGGZAZHZNVKDLG-UHFFFAOYSA-N 0.000 description 1
- ZGGOCCXEJZQOOU-UHFFFAOYSA-N 1-[4-[3-[[2-(hydroxymethyl)-8-propyl-3,4-dihydro-2h-chromen-7-yl]oxy]propoxy]-2-phenylmethoxy-3-propylphenyl]ethanol Chemical compound CCCC1=C(OCCCOC=2C(=C3OC(CO)CCC3=CC=2)CCC)C=CC(C(C)O)=C1OCC1=CC=CC=C1 ZGGOCCXEJZQOOU-UHFFFAOYSA-N 0.000 description 1
- GUGFTMBETUITQJ-UHFFFAOYSA-N 1-[4-[3-[[2-(hydroxymethyl)-8-propyl-3,4-dihydro-2h-chromen-7-yl]oxy]propoxy]-2-phenylmethoxy-3-propylphenyl]ethanone Chemical compound CCCC1=C(OCCCOC=2C(=C3OC(CO)CCC3=CC=2)CCC)C=CC(C(C)=O)=C1OCC1=CC=CC=C1 GUGFTMBETUITQJ-UHFFFAOYSA-N 0.000 description 1
- DWJDEJZHYRTMRR-UHFFFAOYSA-N 2,2-dimethoxypropanal Chemical compound COC(C)(OC)C=O DWJDEJZHYRTMRR-UHFFFAOYSA-N 0.000 description 1
- OIUUSKXUSCHTHO-UHFFFAOYSA-N 2-(2-carboxyethyl)-7-hydroxy-4-oxo-8-propyl-3h-chromene-2-carboxylic acid Chemical compound O=C1CC(CCC(O)=O)(C(O)=O)OC2=C1C=CC(O)=C2CCC OIUUSKXUSCHTHO-UHFFFAOYSA-N 0.000 description 1
- APISVOVOJVZIBA-UHFFFAOYSA-N 2-(triphenyl-$l^{5}-phosphanylidene)acetonitrile Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC#N)C1=CC=CC=C1 APISVOVOJVZIBA-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- AZDUXUXDYSWGDY-UHFFFAOYSA-N 3-(7-hydroxy-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl)propanamide Chemical compound O=C1CC(C)(CCC(N)=O)OC2=C1C=CC(O)=C2CCC AZDUXUXDYSWGDY-UHFFFAOYSA-N 0.000 description 1
- LKJPJRQNDCCZIL-UHFFFAOYSA-N 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl]propanoic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(C)(CCC(O)=O)O2)C2=C1CCC LKJPJRQNDCCZIL-UHFFFAOYSA-N 0.000 description 1
- UMJHJKHRXLZGOL-UHFFFAOYSA-N 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-methyl-8-propyl-3,4-dihydrochromen-2-yl]propanoic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(C)(CCC(O)=O)O2)C2=C1CCC UMJHJKHRXLZGOL-UHFFFAOYSA-N 0.000 description 1
- DIGJYCPJIBWGAS-UHFFFAOYSA-N 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-oxo-8-propyl-2,3-dihydrochromen-2-yl]propanoic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(CCC(O)=O)O2)C2=C1CCC DIGJYCPJIBWGAS-UHFFFAOYSA-N 0.000 description 1
- LUIXKBDJSNNLDB-UHFFFAOYSA-N 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-2h-chromen-2-yl]propanoic acid Chemical compound C1=CC(C(C)=O)=C(O)C(CCC)=C1OCCCOC1=CC=C(C=CC(CCC(O)=O)O2)C2=C1CCC LUIXKBDJSNNLDB-UHFFFAOYSA-N 0.000 description 1
- KULIWZBFGYLXBK-UHFFFAOYSA-N 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanenitrile Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(CCC#N)O2)C2=C1CCC KULIWZBFGYLXBK-UHFFFAOYSA-N 0.000 description 1
- UHAYGLCGMYKNGL-UHFFFAOYSA-N 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanoic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(CCC(O)=O)O2)C2=C1CCC UHAYGLCGMYKNGL-UHFFFAOYSA-N 0.000 description 1
- IZRKWUOTDFQIKT-UHFFFAOYSA-N 4-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl]butanoic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(C)(CCCC(O)=O)O2)C2=C1CCC IZRKWUOTDFQIKT-UHFFFAOYSA-N 0.000 description 1
- RVMGXWBCQGAWBR-UHFFFAOYSA-N 4-oxo-1-benzopyran-2-carboxylic acid Chemical class C1=CC=C2OC(C(=O)O)=CC(=O)C2=C1 RVMGXWBCQGAWBR-UHFFFAOYSA-N 0.000 description 1
- ANVYINVJFUEFFD-UHFFFAOYSA-N 6-(1-hydroxyethyl)-3-[3-[[2-(hydroxymethyl)-8-propyl-3,4-dihydro-2h-chromen-7-yl]oxy]propoxy]-2-propylphenol Chemical compound C1=CC(C(C)O)=C(O)C(CCC)=C1OCCCOC1=CC=C(CCC(CO)O2)C2=C1CCC ANVYINVJFUEFFD-UHFFFAOYSA-N 0.000 description 1
- AXMSQYXIWKOTTL-UHFFFAOYSA-N 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-(2-carboxycyclopropyl)-8-propyl-3,4-dihydrochromene-2-carboxylic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(O2)(C3C(C3)C(O)=O)C(O)=O)C2=C1CCC AXMSQYXIWKOTTL-UHFFFAOYSA-N 0.000 description 1
- NCLKEBMHPJTKIN-UHFFFAOYSA-N 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-(2-carboxyethyl)-4-oxo-8-propyl-3h-chromene-2-carboxylic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(CCC(O)=O)(O2)C(O)=O)C2=C1CCC NCLKEBMHPJTKIN-UHFFFAOYSA-N 0.000 description 1
- LJQNVBLLLSIDLT-UHFFFAOYSA-N 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-(3-carboxypropanoyl)-8-propyl-3,4-dihydrochromene-2-carboxylic acid Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(O2)(C(O)=O)C(=O)CCC(O)=O)C2=C1CCC LJQNVBLLLSIDLT-UHFFFAOYSA-N 0.000 description 1
- AWSOLWLCZQOHBW-UHFFFAOYSA-N 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-methyl-2-(3-oxo-3-pyrrolidin-1-ylpropyl)-8-propyl-3h-chromen-4-one Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(C)(CCC(=O)N2CCCC2)O2)C2=C1CCC AWSOLWLCZQOHBW-UHFFFAOYSA-N 0.000 description 1
- VTOKNBLHBFVCFO-UHFFFAOYSA-N 7-[3-(4-acetyl-3-phenylmethoxy-2-propylphenoxy)propoxy]-8-propyl-3,4-dihydro-2h-chromene-2-carbaldehyde Chemical compound CCCC1=C(OCCCOC=2C(=C3OC(CCC3=CC=2)C=O)CCC)C=CC(C(C)=O)=C1OCC1=CC=CC=C1 VTOKNBLHBFVCFO-UHFFFAOYSA-N 0.000 description 1
- SSZRPCCEZDZMJR-UHFFFAOYSA-N 7-hydroxy-2-methyl-2-(3-oxo-3-pyrrolidin-1-ylpropyl)-8-propyl-3h-chromen-4-one Chemical compound O1C=2C(CCC)=C(O)C=CC=2C(=O)CC1(C)CCC(=O)N1CCCC1 SSZRPCCEZDZMJR-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- UAGJVSRUFNSIHR-UHFFFAOYSA-N Methyl levulinate Chemical compound COC(=O)CCC(C)=O UAGJVSRUFNSIHR-UHFFFAOYSA-N 0.000 description 1
- LOMVENUNSWAXEN-UHFFFAOYSA-N Methyl oxalate Chemical compound COC(=O)C(=O)OC LOMVENUNSWAXEN-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UOIFTOBIGNZZSO-UHFFFAOYSA-N acetic acid;ethyl acetate;hexane Chemical compound CC(O)=O.CCCCCC.CCOC(C)=O UOIFTOBIGNZZSO-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 150000008375 benzopyrones Chemical class 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- BTKSUULMJNNXHG-UHFFFAOYSA-N ethyl 2-(methylamino)acetate Chemical compound CCOC(=O)CNC BTKSUULMJNNXHG-UHFFFAOYSA-N 0.000 description 1
- RVBSOTGMWUENFX-UHFFFAOYSA-N ethyl 3-(7-hydroxy-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl)propanoate Chemical compound O=C1CC(C)(CCC(=O)OCC)OC2=C1C=CC(O)=C2CCC RVBSOTGMWUENFX-UHFFFAOYSA-N 0.000 description 1
- WQNWOZAJDYRARP-UHFFFAOYSA-N ethyl 3-[7-(3-bromopropoxy)-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanoate Chemical compound C1CC(CCC(=O)OCC)OC2=C1C=CC(OCCCBr)=C2CCC WQNWOZAJDYRARP-UHFFFAOYSA-N 0.000 description 1
- ABKKMLSFXOZOHZ-UHFFFAOYSA-N ethyl 3-[7-(oxiran-2-ylmethoxy)-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanoate Chemical compound C1=CC=2CCC(CCC(=O)OCC)OC=2C(CCC)=C1OCC1CO1 ABKKMLSFXOZOHZ-UHFFFAOYSA-N 0.000 description 1
- WEWZLNCPTYDLNP-UHFFFAOYSA-N ethyl 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanoate Chemical compound C1=CC(C(C)=O)=C(O)C(CCC)=C1OCC(O)COC1=CC=C(CCC(CCC(=O)OCC)O2)C2=C1CCC WEWZLNCPTYDLNP-UHFFFAOYSA-N 0.000 description 1
- CKKZPAKJWLFROK-UHFFFAOYSA-N ethyl 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanoate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(CCC(=O)OCC)O2)C2=C1CCC CKKZPAKJWLFROK-UHFFFAOYSA-N 0.000 description 1
- LQVAEVQODVXYKK-UHFFFAOYSA-N ethyl 4-imidazol-1-yl-4-oxobutanoate Chemical compound CCOC(=O)CCC(=O)N1C=CN=C1 LQVAEVQODVXYKK-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- BLWYXBNNBYXPPL-YFKPBYRVSA-N methyl (2s)-pyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1CCCN1 BLWYXBNNBYXPPL-YFKPBYRVSA-N 0.000 description 1
- RWIKCBHOVNDESJ-NSCUHMNNSA-N methyl (e)-4-bromobut-2-enoate Chemical compound COC(=O)\C=C\CBr RWIKCBHOVNDESJ-NSCUHMNNSA-N 0.000 description 1
- FSDCKRBFBQJPCS-UHFFFAOYSA-N methyl 2-(2-methoxycarbonylcyclopropyl)-7-phenylmethoxy-8-propyl-3,4-dihydrochromene-2-carboxylate Chemical compound C1=CC=2CCC(C(=O)OC)(C3C(C3)C(=O)OC)OC=2C(CCC)=C1OCC1=CC=CC=C1 FSDCKRBFBQJPCS-UHFFFAOYSA-N 0.000 description 1
- CKLSQEOWANTQPY-UHFFFAOYSA-N methyl 3-(7-hydroxy-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl)propanoate Chemical compound O=C1CC(C)(CCC(=O)OC)OC2=C1C=CC(O)=C2CCC CKLSQEOWANTQPY-UHFFFAOYSA-N 0.000 description 1
- RYSLWPPTEYGOLP-UHFFFAOYSA-N methyl 3-(7-hydroxy-2-methyl-8-propyl-3,4-dihydrochromen-2-yl)propanoate Chemical compound C1CC(C)(CCC(=O)OC)OC2=C1C=CC(O)=C2CCC RYSLWPPTEYGOLP-UHFFFAOYSA-N 0.000 description 1
- JSQXJRBNRICSCW-UHFFFAOYSA-N methyl 3-[7-(3-bromopropoxy)-2-methyl-8-propyl-3,4-dihydrochromen-2-yl]propanoate Chemical compound C1CC(C)(CCC(=O)OC)OC2=C1C=CC(OCCCBr)=C2CCC JSQXJRBNRICSCW-UHFFFAOYSA-N 0.000 description 1
- CNGBZJFVNJYVIL-UHFFFAOYSA-N methyl 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl]propanoate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(C)(CCC(=O)OC)O2)C2=C1CCC CNGBZJFVNJYVIL-UHFFFAOYSA-N 0.000 description 1
- HFVLZHKZIOAKKF-UHFFFAOYSA-N methyl 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-hydroxy-8-propyl-3,4-dihydro-2h-chromen-2-yl]propanoate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(O)CC(CCC(=O)OC)O2)C2=C1CCC HFVLZHKZIOAKKF-UHFFFAOYSA-N 0.000 description 1
- MZMRNAWVUSXDJR-UHFFFAOYSA-N methyl 4-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-methyl-4-oxo-8-propyl-3h-chromen-2-yl]butanoate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(C)(CCCC(=O)OC)O2)C2=C1CCC MZMRNAWVUSXDJR-UHFFFAOYSA-N 0.000 description 1
- AVVPOKSKJSJVIX-UHFFFAOYSA-N methyl 5-oxohexanoate Chemical compound COC(=O)CCCC(C)=O AVVPOKSKJSJVIX-UHFFFAOYSA-N 0.000 description 1
- AOWAVOUTNMFHOM-UHFFFAOYSA-N methyl 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-(2-methoxycarbonylcyclopropyl)-8-propyl-3,4-dihydrochromene-2-carboxylate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(O2)(C3C(C3)C(=O)OC)C(=O)OC)C2=C1CCC AOWAVOUTNMFHOM-UHFFFAOYSA-N 0.000 description 1
- DKRLSUSDXMQZLB-UHFFFAOYSA-N methyl 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-(3-methoxy-3-oxopropyl)-4-oxo-8-propyl-3h-chromene-2-carboxylate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(C(=O)CC(CCC(=O)OC)(O2)C(=O)OC)C2=C1CCC DKRLSUSDXMQZLB-UHFFFAOYSA-N 0.000 description 1
- PPLNGIRHOQACOD-UHFFFAOYSA-N methyl 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-(4-ethoxy-4-oxobutanoyl)-8-propyl-3,4-dihydrochromene-2-carboxylate Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1OCCCOC1=CC=C(CCC(O2)(C(=O)CCC(=O)OCC)C(=O)OC)C2=C1CCC PPLNGIRHOQACOD-UHFFFAOYSA-N 0.000 description 1
- WQKFRXWCVQIRBK-UHFFFAOYSA-N methyl 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-oxo-8-propylchromene-2-carboxylate Chemical compound C1=CC(C(C)=O)=C(O)C(CCC)=C1OCCCOC1=CC=C2C(=O)C=C(C(=O)OC)OC2=C1CCC WQKFRXWCVQIRBK-UHFFFAOYSA-N 0.000 description 1
- OBWJNQIGGOXILZ-UHFFFAOYSA-N methyl 7-hydroxy-2-(2-methoxycarbonylcyclopropyl)-8-propyl-3,4-dihydrochromene-2-carboxylate Chemical compound O1C=2C(CCC)=C(O)C=CC=2CCC1(C(=O)OC)C1CC1C(=O)OC OBWJNQIGGOXILZ-UHFFFAOYSA-N 0.000 description 1
- SKMMYCPHDOTVQZ-UHFFFAOYSA-N methyl 7-hydroxy-2-(3-methoxy-3-oxopropyl)-4-oxo-8-propyl-3h-chromene-2-carboxylate Chemical compound O=C1CC(CCC(=O)OC)(C(=O)OC)OC2=C1C=CC(O)=C2CCC SKMMYCPHDOTVQZ-UHFFFAOYSA-N 0.000 description 1
- KVOGUBVPDGCBIO-UHFFFAOYSA-N methyl 7-hydroxy-4-oxo-8-propylchromene-2-carboxylate Chemical compound O1C(C(=O)OC)=CC(=O)C2=C1C(CCC)=C(O)C=C2 KVOGUBVPDGCBIO-UHFFFAOYSA-N 0.000 description 1
- WGXYLEBIIZKRGA-UHFFFAOYSA-N methyl 7-hydroxy-8-propyl-3,4-dihydro-2h-chromene-2-carboxylate Chemical compound C1CC(C(=O)OC)OC2=C1C=CC(O)=C2CCC WGXYLEBIIZKRGA-UHFFFAOYSA-N 0.000 description 1
- OMJCNOZYFIZCAM-UHFFFAOYSA-N methyl 7-phenylmethoxy-8-propyl-3,4-dihydro-2h-chromene-2-carboxylate Chemical compound C1=CC=2CCC(C(=O)OC)OC=2C(CCC)=C1OCC1=CC=CC=C1 OMJCNOZYFIZCAM-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- GWLJTAJEHRYMCA-UHFFFAOYSA-N phospholane Chemical compound C1CCPC1 GWLJTAJEHRYMCA-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- IIHPVYJPDKJYOU-UHFFFAOYSA-N triphenylcarbethoxymethylenephosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCC)C1=CC=CC=C1 IIHPVYJPDKJYOU-UHFFFAOYSA-N 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52097383A | 1983-08-08 | 1983-08-08 | |
| US520973 | 1983-08-08 | ||
| US560355 | 1983-12-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6042378A JPS6042378A (ja) | 1985-03-06 |
| JPS628432B2 true JPS628432B2 (enrdf_load_stackoverflow) | 1987-02-23 |
Family
ID=24074815
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1497884A Granted JPS6042378A (ja) | 1983-08-08 | 1984-01-30 | 代謝阻害作用を有する新規化合物 |
| JP18610386A Granted JPS6270368A (ja) | 1983-08-08 | 1986-08-07 | 置換１−ベンゾピラン−２−イル−プロパン酸 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18610386A Granted JPS6270368A (ja) | 1983-08-08 | 1986-08-07 | 置換１−ベンゾピラン−２−イル−プロパン酸 |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS6042378A (enrdf_load_stackoverflow) |
| ZA (1) | ZA84345B (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5073562A (en) * | 1990-05-10 | 1991-12-17 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
-
1984
- 1984-01-17 ZA ZA84345A patent/ZA84345B/xx unknown
- 1984-01-30 JP JP1497884A patent/JPS6042378A/ja active Granted
-
1986
- 1986-08-07 JP JP18610386A patent/JPS6270368A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6270368A (ja) | 1987-03-31 |
| JPH0250113B2 (enrdf_load_stackoverflow) | 1990-11-01 |
| JPS6042378A (ja) | 1985-03-06 |
| ZA84345B (en) | 1985-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4675332A (en) | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents | |
| EP0061800B1 (en) | Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them | |
| KR910007970B1 (ko) | 4h-1-벤조피란-4-온 유도체 또는 이의 염, 이의 제조방법 및 활성 성분으로서 이를 함유하는 약제학적 조성물 | |
| JPH0631206B2 (ja) | 新規７‐置換クロマン誘導体 | |
| US4665203A (en) | Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors | |
| CA1210770A (en) | Leukotriene antagonists | |
| EP0139809B1 (en) | Substituted dihydrobenzopyrans | |
| KR100378892B1 (ko) | 류코트리엔-길항활성을갖는벤조피란유도체 | |
| RU2012554C1 (ru) | Способ получения производных бензоциклоалкенилдигидрооксиалкановых кислот | |
| KR20030023767A (ko) | 아미노알킬벤조일-벤조푸란 또는 벤조티오펜 유도체, 그의제조방법 및 그를 포함하는 조성물 | |
| JP5140226B2 (ja) | アミノアルコキシベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体、その製造方法およびそれを含む組成物 | |
| JPH0383979A (ja) | 新規ベンゾピランおよびベンゾチオピラン誘導体 | |
| US4486428A (en) | Bicyclic benzo fused compounds | |
| US4778903A (en) | Substituted dihydrobenzopyrans | |
| EP0309541A1 (en) | SULFONYLCARBOXAMIDE. | |
| AU610379B2 (en) | New heteroarotinoid derivatives, processes for preparing them and pharmaceutical compositions containing them | |
| JPS628432B2 (enrdf_load_stackoverflow) | ||
| US5006549A (en) | Novel 7-aroyl-4-hydroxy-3-methyl-benzofurans as dual inhibitors of cyclooxygenase and 5-lipoxygenase | |
| US5155130A (en) | Certain benzopyran and benzothiopyran derivatives | |
| JPH07119188B2 (ja) | カルコン誘導体 | |
| JPS62240639A (ja) | ジフエニルメタン化合物類 | |
| KR0155556B1 (ko) | 치환된 디벤조푸란 및 이것의 사용방법 | |
| US4952705A (en) | Substituted dihydrobenzopyrans | |
| JPH08508515A (ja) | 二環式カルボン酸ロイコトリエンｂ▲下４▼拮抗物質 | |
| US4888356A (en) | Use of substituted dihydrobenzopyrans for allergy and inflammation |